Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation

by Lidia Staszewsky, Jennifer M. T. A. Meessen, Deborah Novelli, Ursula-Henrike Wienhues-Thelen, Marcello Disertori, Aldo P. Maggioni, Serge Masson, Gianni Tognoni, Maria Grazia Franzosi, Donata Lucci, Roberto Latini
Published 2021-11-01

Frailty Questionnaire Is Not a Strong Prognostic Factor for Functional Outcomes in Hip or Knee Arthroplasty Patients

by Jennifer M. T. A. Meessen MSc, Marta Fiocco PhD, Claudia S. Leichtenberg MSc, Thea P. M. Vliet Vlieland PhD, MD, P. Eline Slagboom PhD, Rob G. H. H. Nelissen PhD, MD
Published 2019-01-01

IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study

by Jennifer M. T. A. Meessen, Giulia Cesaroni, Gian F. Mureddu, Alessandro Boccanelli, Ursula-Henrike Wienhues-Thelen, Peter Kastner, Luisa Ojeda-Fernandez, Deborah Novelli, Gianfranco Bazzoni, Maurizio Mangiavacchi, Nera Agabiti, Serge Masson, Lidia Staszewsky, Roberto Latini, on behalf of the PREDICTOR Investigators
Published 2021-07-01

Amplitude Spectrum Area of ventricular fibrillation to guide defibrillation: a small open-label, pseudo-randomized controlled multicenter trialResearch in context

by Laura Ruggeri, Francesca Fumagalli, Filippo Bernasconi, Federico Semeraro, Jennifer M.T.A. Meessen, Adriana Blanda, Maurizio Migliari, Aurora Magliocca, Giovanni Gordini, Roberto Fumagalli, Giuseppe Sechi, Antonio Pesenti, Markus B. Skrifvars, Yongqin Li, Roberto Latini, Lars Wik, Giuseppe Ristagno
Published 2023-04-01

Patient-reported outcome measures in patients with familial cerebral cavernous malformations: results from the Treat_CCM trial

by Jennifer M. T. A. Meessen, Giorgia Abete-Fornara, Barbara Zarino, Marco Castori, Laura Tassi, Maria R. Carriero, Q. G. D'Alessandris, R. Al-Shahi Salman, Adriana Blanda, Enrico B. Nicolis, Deborah Novelli, Maria Caruana, Antonella Vasamì, Silvia Lanfranconi, Roberto Latini
Published 2024-02-01

Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial

by Laura Alagna, Jennifer M. T. A. Meessen, Giacomo Bellani, Daniela Albiero, Pietro Caironi, Irene Principale, Luigi Vivona, Giacomo Grasselli, Francesca Motta, Nicolò M. Agnelli, Vieri Parrini, Stefano Romagnoli, Roberto Keim, Francesca Di Marzo Capozzi, Fabio S. Taccone, Walter Taccone, Barbara Bottazzi, Alessandra Bandera, Andrea Cortegiani, Roberto Latini
Published 2021-11-01

Circulating biomarkers in familial cerebral cavernous malformationResearch in context

by Francesca Lazzaroni, Jennifer M.T.A. Meessen, Ying Sun, Silvia Lanfranconi, Elisa Scola, Quintino Giorgio D'Alessandris, Laura Tassi, Maria Rita Carriero, Marco Castori, Silvia Marino, Adriana Blanda, Enrico B. Nicolis, Deborah Novelli, Roberta Calabrese, Nicolò M. Agnelli, Barbara Bottazzi, Roberto Leone, Selene Mazzola, Silvia Besana, Carlotta Catozzi, Luigi Nezi, Maria G. Lampugnani, Matteo Malinverno, Nastasja Grdseloff, Claudia J. Rödel, Behnam Rezai Jahromi, Niccolò Bolli, Francesco Passamonti, Peetra U. Magnusson, Salim Abdelilah-Seyfried, Elisabetta Dejana, Roberto Latini
Published 2024-01-01

Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial

by Jennifer M.T.A. Meessen, Daniela Cardinale, Fabio Ciceri, Maria Teresa Sandri, Maurizio Civelli, Barbara Bottazzi, GianFranco Cucchi, Elisabetta Menatti, Maurizio Mangiavacchi, Gianluigi Condorelli, Enrico Barbieri, Stefania Gori, Alessandro Colombo, Giuseppe Curigliano, Michela Salvatici, Paolo Pastori, Francesco Ghisoni, Alessandra Bianchi, Cristina Falci, Pietro Cortesi, Alberto Farolfi, Anna Monopoli, Carlo Milandri, Marco Bregni, Alessandra Malossi, Daniele Nassiacos, Claudio Verusio, Lidia Staszewsky, Roberto Leone, Deborah Novelli, Giovanna Balconi, Enrico B. Nicolis, Maria Grazia Franzosi, Serge Masson, Cecilia Garlanda, Alberto Mantovani, Carlo M. Cipolla, Roberto Latini, ICOS‐ONE Study Investigators
Published 2020-08-01

Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling

by Nicolien A. van Vliet, Maxime M. Bos, Carisha S. Thesing, Layal Chaker, Maik Pietzner, Evelyn Houtman, Matt J. Neville, Ruifang Li-Gao, Stella Trompet, Rima Mustafa, Fariba Ahmadizar, Marian Beekman, Mariska Bot, Kathrin Budde, Constantinos Christodoulides, Abbas Dehghan, Christian Delles, Paul Elliott, Marina Evangelou, He Gao, Mohsen Ghanbari, Antonius E. van Herwaarden, M. Arfan Ikram, Martin Jaeger, J. Wouter Jukema, Ibrahim Karaman, Fredrik Karpe, Margreet Kloppenburg, Jennifer M. T. A. Meessen, Ingrid Meulenbelt, Yuri Milaneschi, Simon P. Mooijaart, Dennis O. Mook-Kanamori, Mihai G. Netea, Romana T. Netea-Maier, Robin P. Peeters, Brenda W. J. H. Penninx, Naveed Sattar, P. Eline Slagboom, H. Eka D. Suchiman, Henry Völzke, Ko Willems van Dijk, Raymond Noordam, Diana van Heemst, BBMRI Metabolomics Consortium
Published 2021-11-01